Skip to content

Bioventus BVS Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin68.7%+1.2pp68.3%+0.6pp67.8%+0.8pp67.6%+1.1pp67.4%+1.9pp
Net margin4.9%+10.9pp4%+10.3pp1.3%+8.9pp-0.1%+8.1pp-6%-1.8pp
Returns
Return on equity16.9%+38.1pp13.7%+36.2pp4.8%+30.5pp-0.5%+25.9pp-21.2%-9.0pp
Return on invested capital12.3%+18.4pp11.9%+18.2pp5.2%+9.4pp3.5%+7.9pp-6.1%-8.5pp
Efficiency
Asset turnover0.9×+0.1×0.8×+0.1×0.8×+0.1×0.8×+0.1×0.8×+0.1×
Liquidity
Current ratio1.7×+0.3×1.7×+0.4×1.7×+0.3×1.5×+0.1×1.4×-0.1×
Leverage
Debt-to-equity1.5×-0.9×1.7×-0.7×2.1×-0.7×2.2×-0.5×2.5×0.0×
Net debt / EBITDA2.4×-17.0×2.6×-15.3×4.1×4.9×19.5×
Per Share
Book value per share$2.70+20.2%$2.67+16.6%$2.41+5.9%$2.35-0.2%$2.24-17.0%
Valuation
Market capitalization$659.19M+51.7%$498.3M-27.4%$447.51M-41.5%$448.58M+23.1%$605.34M+83.7%
Price / sales1.1×+0.4×0.9×-0.3×0.8×-0.6×0.8×+0.1×1.1×+0.4×
Price / book3.5×+0.6×2.7×-1.9×2.7×-2.5×2.8×+0.4×4.1×+2.2×
EV / EBITDA8.8×-35.4×7.5×-49.3×10.2×11.7×53.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Bioventus's profit margins?
Bioventus (BVS) runs a 68.7% gross margin and a 10.0% operating margin, with a 4.9% net margin.
Where do Bioventus's ratios come from?
Every ratio is computed from Bioventus's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.